Areas of concern are the recruitment of talented scientists, as well as retaining access to EU funding, European research collaborations, and clinical trials.
Investigators studied 442 patients with CUP and found mutations that could inform a specific treatment decision in more than half of them.
Using data from TCGA and the HPA, they looked at the prognostic role of each protein-coding gene in 7,932 tumor samples spanning 17 different tumor types.
The new SR-Plex system comes without integrated sample prep, making it less expensive and more amenable to non-protein work like nucleic acid assays.
The collaboration will place T1D in the field of precision medicine, potentially allowing JDRF to identify factors that potentially lead to T1D.
The project aims to developa system to automate the coring of tumor samples based on identified targets for DNA and RNA extraction.
The firm is looking for outside partners to tackle test commercialization as it begins to bring its second-generation colorectal cancer assay to market.
The Belgian company recently received €3.6 million to develop the signature into a clinical test within the next three years.
The agricultural company said it will use the licensed technology to develop improved and sustainable crops.
Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.
US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.
A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.
In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.